Protective effect of EPO on early diabetic rat's kidney
- VernacularTitle:EPO对早期糖尿病大鼠肾脏的保护作用
- Author:
Li LING
;
Benzhang ZHU
- Publication Type:Journal Article
- Keywords:
diabetic nephropathy;
EPO;
cell apoptosis;
Bcl-2/Bax;
VEGF;
rat
- From:
Journal of Xi'an Jiaotong University(Medical Sciences)
2003;0(06):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the effect of sub-clinical dosage of EPO on early renal lesions of diabetic rats. Methods The rats were randomly divided into normal control group (NC), diabetic group (DM), diabetic rats treated with A-dosage EPO (DMTA), and diabetic rats treated with B-dosage EPO (DMTB). Diabetic rats induced by STZ were given EPO intraperitoneally for 10 weeks; then blood glucose, blood pressure, renal function indexes, renal morphological parameter, the expression of cell apoptosis associated protein Bcl-2/Bax and VEGF were measured. Results After treatment of EPO, renal functional and morphological indexes were improved significantly and the ratio of Bcl-2/Bax and VEGF increased, both in a dose-dependent manner. Blood sugar, blood pressure and hemoglobin concentration had no significant differences. Conclusion Sub-clinical dosage of EPO could play an advantageous role in diabetic nephropathy. Inhibition of cell apoptosis by upregulation of Bcl-2/Bax expression rate may be responsible for renal protective effects despite the upregulation of VEGF.
